← Back to Search

MANUP for Type 2 Diabetes (MANUP-NC Trial)

N/A
Waitlist Available
Research Sponsored by North Carolina Central University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
1) reside in Halifax, County or Alamance County NC; 2) age 21 or older; (3) English language proficient; 4) able to walk unaided; 4) self-reported type 2 diabetes diagnosis.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

MANUP-NC Trial Summary

This trial will examine if a culturally-tailored diabetes education program helps lower A1c in Black men, with the goal of improving diabetes outcomes in this population.

Eligible Conditions
  • Type 2 Diabetes
  • Self-Efficacy
  • Male Gender Identity
  • Coping Behavior

MANUP-NC Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

MANUP-NC Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
A1c

MANUP-NC Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Active intervention group (AI)Experimental Treatment1 Intervention
The active intervention group (AI) receiving the active treatment (MANUP intervention) which include diabetes education, diabetes support with a focus on coping techniques (based on John Henryism concepts), physical activity engagement and motivational text messages.
Group II: Delayed intervention group (DI)Active Control1 Intervention
DI participants will only receive motivational text-messages. They will then "flip" and receive full intervention after the AI group has completed the program.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MANUP
2022
N/A
~50

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillOTHER
1,499 Previous Clinical Trials
4,176,283 Total Patients Enrolled
North Carolina Central UniversityLead Sponsor
3 Previous Clinical Trials
14,628 Total Patients Enrolled

Media Library

MANUP Clinical Trial Eligibility Overview. Trial Name: NCT05038176 — N/A
Type 2 Diabetes Research Study Groups: Active intervention group (AI), Delayed intervention group (DI)
Type 2 Diabetes Clinical Trial 2023: MANUP Highlights & Side Effects. Trial Name: NCT05038176 — N/A
MANUP 2023 Treatment Timeline for Medical Study. Trial Name: NCT05038176 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently being accepted for this clinical trial?

"This trial is currently looking for suitable candidates. Clinicaltrials.gov first posted this research study on February 12th 2022 and the information was most recently modified on March 9th 2022."

Answered by AI

How many participants have been enrolled in this clinical experiment?

"Affirmative. The clinical trial is currently accruing participants, as indicated on the official clinicaltrials.gov page which was first posted on February 12th 2022 and most recently updated on March 9th 2022. 50 individuals are required to partake in this study at a single medical facility."

Answered by AI
~16 spots leftby Mar 2025